SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-23-170130
Filing Date
2023-06-20
Accepted
2023-06-20 16:06:50
Documents
8

Document Format Files

Seq Description Document Type Size
1 SC14D9C d444600dsc14d9c.htm SC14D9C 20367
2 EX-99.1 d444600dex991.htm EX-99.1 18306
3 EX-99.2 d444600dex992.htm EX-99.2 15017
4 EX-99.3 d444600dex993.htm EX-99.3 19808
5 EX-99.4 d444600dex994.htm EX-99.4 12023
6 GRAPHIC g444600dsp15.jpg GRAPHIC 7269
7 GRAPHIC g444600dsp15a.jpg GRAPHIC 2560
8 GRAPHIC g444600dsp15b.jpg GRAPHIC 3483
  Complete submission text file 0001193125-23-170130.txt   106353
Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filed by) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1230
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Subject) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1230
Type: SC14D9C | Act: 34 | File No.: 005-92879 | Film No.: 231025080
SIC: 2834 Pharmaceutical Preparations